Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ABLATE Registry: Radiofrequency Ablation After Breast Lumpectomy (eRFA) Added To Extend Intraoperative Margins in the Treatment of Breast Cancer

NCT01153035 is registered in ClinicalTrials.gov with University of Arkansas as lead sponsor.

NCT NCT01153035
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01153035 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ABLATE Registry: Radiofrequency Ablation After Breast Lumpectomy (eRFA) Added To Extend Intraoperative Margins in the Treatment of Breast Cancer
Lead sponsor
University of Arkansas
Phase
Not applicable
Overall status
Active, not recruiting
Start date
June 30, 2010
Completion date
June 30, 2027
Enrollment
104 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer